skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: British Journal Of Cancer remover assunto: Cancer Therapies remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials

CESNE, A. L ; JUDSON, I ; BLAY, J.-Y ; MAKI, R ; GROSSO, F ; SCHUETZE, S ; MEHREN, M. V ; CHAWLA, S. P ; DEMETRI, G. D ; NIETO, A ; TANOVIC, A

British journal of cancer, 2013-10, Vol.109 (7), p.1717-1724 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

CASSIER, P. A ; LEFRANC, A ; DOMONT, J ; ITALIANO, A ; DUFFAUD, F ; CADORE, A.-C ; POLIVKA, V ; BLAY, J.-Y ; AMELA, E. Y ; CHEVREAU, C ; BUI, B. N ; LECESNE, A ; RAY-COQUARD, I ; CHABAUD, S ; PENEL, N ; BERGE, Y

British journal of cancer, 2013-08, Vol.109 (4), p.909-914 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

SLEIJFER, S ; GORLIA, T ; HOHENBERGER, P ; LAMERS, C ; BURGER, H ; BLAY, J.-Y ; LE CESNE, A ; SCURR, M ; COLLIN, F ; PANDITE, L ; MARREAUD, S

British journal of cancer, 2012-08, Vol.107 (4), p.639-645 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours
Material Type:
Artigo 		Adicionar ao Meu Espaço

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

Adenis, A ; Ray-Coquard, I ; Italiano, A ; Chauzit, E ; Bui-Nguyen, B ; Blay, J-Y ; Tresch-Bruneel, E ; Fournier, C ; Clisant, S ; Amela, E Y ; Cassier, P A ; Molimard, M ; Penel, N

British journal of cancer, 2013-11, Vol.109 (10), p.2574-2578 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Penel, N ; Glabbeke, M V ; Mathoulin-pelissier, S ; Judson, I ; Sleijfer, S ; Bui, B ; Schoffski, P ; Ouali, M ; Marreaud, S ; Brouste, V ; Duhamel, A ; Hohenberger, P ; Blay, J-y

British journal of cancer, 2011-05, Vol.104 (10), p.1544-1550 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

Ray-Coquard, I ; Borg, C ; Bachelot, Th ; Sebban, C ; Philip, I ; Clapisson, G ; A Le Cesne ; Biron, P ; Chauvin, F ; Blay, J Y

British journal of cancer, 2003-01, Vol.88 (2), p.181 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series
Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series

Carlino, Matteo S ; Vanella, Vito ; Girgis, Christina ; Giannarelli, Diana ; Guminski, Alex ; Festino, Lucia ; Kefford, Richard F ; Menzies, Alexander M ; Long, Georgina V ; Ascierto, Paolo A

British journal of cancer, 2016-11, Vol.115 (11), p.1280-1284 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

KANG, Y.-K ; YOO, C ; RYU, M.-H ; RYOO, B.-Y ; LEE, J. J ; TAN, E ; PARK, I ; PARK, J. H ; CHOI, Y. J ; JO, J ; RYU, J.-S

British journal of cancer, 2013-10, Vol.109 (9), p.2309-2315 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment

D'INCALCI, M ; BADRI, N ; GALMARINI, C. M ; ALLAVENA, P

British journal of cancer, 2014-08, Vol.111 (4), p.646-650 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms

Romano, Michela ; Della Porta, Matteo Giovanni ; Gallì, Anna ; Panini, Nicolò ; Licandro, Simonetta Andrea ; Bello, Ezia ; Craparotta, Ilaria ; Rosti, Vittorio ; Bonetti, Elisa ; Tancredi, Richard ; Rossi, Marianna ; Mannarino, Laura ; Marchini, Sergio ; Porcu, Luca ; Galmarini, Carlos M ; Zambelli, Alberto ; Zecca, Marco ; Locatelli, Franco ; Cazzola, Mario ; Biondi, Andrea ; Rambaldi, Alessandro ; Allavena, Paola ; Erba, Eugenio ; D'Incalci, Maurizio

British journal of cancer, 2017-01, Vol.116 (3), p.335-343 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2002  (3)
  2. 2002Até2006  (5)
  3. 2007Até2011  (5)
  4. 2012Até2015  (23)
  5. Após 2015  (7)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.